common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

Phase 1 Study to Assess AER-271

The objective of this Phase 1 trial is to assess the safety, tolerability and pharmacokinetics of AER-271 in health subjects.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - AER-271

AER-271, the test article for this study.

Drug - Placebo

Placebo control for this study.

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Sequential-Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of AER-271 in Healthy Subjects

common.study.values.clinical-trial-id

NCT03804476

participant.views.study.view.id

eER1Ka